(PharmaNewsWire.Com, March 07, 2018 ) Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
By Region / Countries North America (U.S., Canada, Mexico) Europe (Germany, U.K., France, Italy, Russia, Spain etc) South America (Brazil, Argentina etc) Middle East & Africa (Saudi Arabia, South Africa etc)
By Type Tablet Capsule
By End-User / Application Analgesic Opioid Antagonist
By Company Siegfried Sanofi Johnson Matthey Mallinckrodt Noramco Unichemlabs Arevipharma Resonance-labs Sun Pharma RusanPharma Micro OrgoChem Faranshimi
About Us: Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. Were associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: